• Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
HBOT News Network Logo
  • Home
  • Special Reports
  • News & Research
  • Conversations
  • Research Rundowns
  • International Indications
Veterans Special Report
  • Home
  • Special Reports
  • News & Research
  • Conversations
  • Research Rundowns
  • International Indications

Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy.

by HBOT News | Jun 2, 2005 | Myeloma

Abstract: The current report presented 17 patients with cancer with bone metastases and 1 patient with osteopenia who received treatment with bisphosphonates and who subsequently developed osteonecrosis of the mandible and/or maxilla. The authors reviewed information...

Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy.

by HBOT News | Jun 2, 2005 | Lymphoma

Abstract: The current report presented 17 patients with cancer with bone metastases and 1 patient with osteopenia who received treatment with bisphosphonates and who subsequently developed osteonecrosis of the mandible and/or maxilla. The authors reviewed information...

Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy.

by HBOT News | Jun 2, 2005 | Carcinoma

Abstract: The current report presented 17 patients with cancer with bone metastases and 1 patient with osteopenia who received treatment with bisphosphonates and who subsequently developed osteonecrosis of the mandible and/or maxilla. The authors reviewed information...

Osseointegration in irradiated cancer patients: an analysis with respect to implant failures.

by HBOT News | May 11, 2005 | Cancer

Abstract: This study retrospectively evaluated implant survival of 631 osseointegrated implants installed in irradiated cancer patients over a 25-year period. The files of 107 patients followed since 1979 were evaluated. Factors influencing implant survival as...

Hyperbaric oxygen therapy for radiation induced proctopathy in men treated for prostate cancer.

by HBOT News | May 3, 2005 | Cancer

Abstract: Radiation proctitis is a common complication following external beam radiation therapy and brachytherapy for prostate cancer. While 95% percent of radiation induced proctitis is temporary and self-limiting, up to 5% of patients experience toxicities that are...
« Older Entries
Next Entries »

Recent Posts

  • Treat the Concussion: How HBOT Is Changing the Playbook for Concussions — An Interview with Dr. Daphne Denham
  • Understanding Hyperbaric Chambers: Types, Risks, and Safety Tips for Patients
  • Overcoming the Placebo Challenge: New Trial Confirms HBOT Benefits for TBI and PTSD
  • Concussion Recovery: New Study Supports HBOT for Student Athletes
  • Can Oxygen Make You Younger? What Bryan Johnson’s $2M HBOT Experiment Really Tells Us

Archives

Categories

Hyperbaric Oxygen Therapy is used around the world to extend and improve quality of life by augmenting the treatment of all injuries, diseases and infections, as well as to improve overall wellness. HBOT involves breathing 100% oxygen in a pressurized chamber to increase oxygen levels in blood plasma. A century of clinical research has shown that increased oxygen in plasma accelerates our natural ability to heal through neurogenesis and angiogenesis.
  • Follow
  • Follow
  • Follow
  • Follow
  • Policies
  • Contact

Our Newsletter

Join our mailing list and get notified when we publish news or record new episodes.

Name(Required)

© 2015-2023 HBOT News – Your news source for the latest news and research about hyperbaric oxygen therapy.